• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

XTend Medical CEO Discusses Company's Business Model; Company Also Launches New Corporate Website

Posted on: Wednesday, 24 October 2007, 06:00 CDT

SUN VALLEY, Calif., Oct. 24, 2007 (PRIME NEWSWIRE) -- XTend Medical Corporation (Pink Sheets:XMDC) announced the company has launched a new corporate website. The new website is located at www.xtendmedical.com

In other news, CEO, Paul D. Lisenby issued the following statement regarding the company's business model and future for the company.

"We've worked very hard over the last month in structuring the company after our reverse merger with Summus Networks for success in the healthcare industry. The company has signed several strategic alliances and purchased a 25% interest in Medical Cost Management. By accomplishing this, we have positioned ourselves for our initial penetration into the healthcare industry and we're very near closing several contracts we've been working on for the past several months. We'd certainly like to speed up the process in closing these contracts, but when dealing with large healthcare organizations this does take time.

"The healthcare industry will continue to grow and XTend Medical is in a prime position to capitalize on these opportunities. Our initial focus will be on delivering products in the diabetic sector. This will allow us to gain monthly revenues that will have a 30-40% profit margin and help us reach our initial sales goals previously released. In addition, we will continue to look for acquisitions and alliances that will bring immediate revenue opportunities to the company. We're confident the company is poised to be a force within the industry. The strengths of the company are our targeted growing sector with cutting-edge technologies, our strong relationships with healthcare companies, and our programs and products designed to raise patient care while lowering costs for the managed care companies.

"I would also like to point out that all of the shares issued to the executives of the company, after the reverse merger with Summus, and the shares used to acquire Medical Cost Management are restricted under Rule 144. No insiders can sell any shares for at least a year. Our total commitment is to grow this company and bring value to all shareholders."

About XTend Medical

XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients. www.xtendmedical.com

Safe Harbor

This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.

This news release was distributed by PrimeNewswire, www.primenewswire.com

CONTACT: FutureTechIR for XTend Medical Corporation Investor Relations (817) 812-2105

Source: PrimeNewswire

More News in this Category